Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
1/3/2025
Eli Lilly China Launches Zepbound (tirzepatide) for Diabetes and Weigh...
12/25/2024
China NMPA Accepts NDA for ARS Pharma's Epinephrine Nasal Spray
12/23/2024
CORXEL Acquires ex-Greater China Rights to an Oral Small Molecule GLP...
12/18/2024
Gan & Lee Cleared for the U.S. IND for Bi-weekly GLP-1RA GZR18 Injecti...
12/12/2024
ARS Pharma Files for Approval of Neffy in China, Japan and Australia
12/10/2024
Eli Lilly Plans to Launch Weight Loss Drug in China Soon
12/9/2024
Domestic Pharma Cos Poised to Gain in Chinese GLP-1 Obesity Drug Marke...
12/3/2024
Sanofi Allocates €1 Billion for New Insulin Manufacturing Facility in...
11/27/2024
CMS's CMS-D005 Gets Green Light for Its Obesity Drug Trials in China
11/18/2024
Novo Nordisk Launches Weight Loss Drug Wegovy in China
11/13/2024
Shanghai Pharma Considers API Partnerships with Indian Drugmakers amid...
11/12/2024
Shanghai Pharma Eyes Stronger India Partnership for Global Growth
11/6/2024
Novo Nordisk Reports Strong Growth in China for 3Qs of 2024, Driven by...
10/30/2024
Eli Lilly's Weight-Loss Drug Mounjaro Set to Debut in Hong Kong
10/25/2024
China Succeeds in Reducing Premature Death from Chronic Diseases
10/21/2024
China Releases First National Guidelines for Obesity Diagnosis and Tre...
10/21/2024
China Sees Drop in Deaths from Chronic Diseases as Efforts Intensify A...
10/17/2024
Gan & Lee Achieves Primary Endpoints in Phase 2 Trials of Three Diabet...
10/15/2024
BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
10/15/2024
Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
10/1/2024
Kailera Secures $400M Series A Funding to Develop Obesity and Diabetes...
9/9/2024
NHC Issues the List of Pediatric Drugs Encouraged for R&D and Registra...
8/27/2024
BrightGene Announces Positive Phase II Results for Diabetes Drug BGM05...
8/26/2024
Recent Study Reveals Alarming Rise in Obesity-Related Cancers in China
8/1/2024
NMPA Accepts NDA for Innovent's T2D Drug Mazdutide
7/22/2024
Gan & Lee Unveils Promising Mid-Stage Data for Homegrown Obesity Drug
7/19/2024
Eli Lilly Wins Label Expansion for Tirzepatide in China
7/19/2024
Experts Predict Novo Victory in Grueling Chinese Patent Case (MedWatcj...
7/18/2024
India's Pharma Contract Manufacturing Sector Set to Double in Three Ye...
7/10/2024
China Initiates New Awareness Campaign to Address Rising Obesity Rates
Page:
2
/
42
Total number of articles:
1256
:
[First]
[<<]
[1]
[2]
[3]
[4]
[5]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit